Free Newsletter
Scientists map genetic mutations in cancer
British scientists have mapped about 200 genetic mutations involved in breast and colon cancer, work that is likely to speed new diagnostics as well as new therapies customized for each individual patient. The researchers concluded that each tumor appears to be unique, giving credence to their conclusion that these cancers are far more complex than previously thought. And the work identified cancer genes that previously had not been identified. The report, which appears in Science, gives drug developers more targets for developing therapies that can be targeted at individual patients.
- read this BBC report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: